Creating an interactive map visualising the geographic variations of the burden of diabetes to inform policymaking: An example from a cohort study in Tasmania, Australia.

costs data linkage diabetes geospatial mapping mortality prevalence

Journal

Australian and New Zealand journal of public health
ISSN: 1753-6405
Titre abrégé: Aust N Z J Public Health
Pays: United States
ID NLM: 9611095

Informations de publication

Date de publication:
26 Dec 2023
Historique:
received: 16 05 2023
revised: 16 08 2023
accepted: 07 11 2023
medline: 2 3 2024
pubmed: 2 3 2024
entrez: 1 3 2024
Statut: aheadofprint

Résumé

To visualise the geographic variations of diabetes burden and identify areas where targeted interventions are needed. Using diagnostic criteria supported by hospital codes, 51,324 people with diabetes were identified from a population-based dataset during 2004-2017 in Tasmania, Australia. An interactive map visualising geographic distribution of diabetes prevalence, mortality rates, and healthcare costs in people with diabetes was generated. The cluster and outlier analysis was performed based on statistical area level 2 (SA2) to identify areas with high (hot spot) and low (cold spot) diabetes burden. There were geographic variations in diabetes burden across Tasmania, with highest age-adjusted prevalence (6.1%), excess cost ($2627), and annual costs per person ($5982) in the West and Northwest. Among 98 SA2 areas, 16 hot spots and 25 cold spots for annual costs, and 10 hot spots and 10 cold spots for diabetes prevalence were identified (p<0.05). 15/16 (94%) and 6/10 (60%) hot spots identified were in the West and Northwest. We have developed a method to graphically display important diabetes outcomes for different geographical areas. The method presented in our study could be applied to any other diseases, regions, and countries where appropriate data are available to identify areas where interventions are needed to improve diabetes outcomes.

Identifiants

pubmed: 38429224
pii: S1326-0200(23)05286-X
doi: 10.1016/j.anzjph.2023.100109
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100109

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: MJ is a member of the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA).

Auteurs

Ngan T T Dinh (NTT)

Menzies Institute for Medical Research, University of Tasmania, Tasmania, Australia; Thai Nguyen University of Medicine and Pharmacy, Thai Nguyen University, Thai Nguyen, Vietnam. Electronic address: https://twitter.com/@NganDin46229988.

Barbara de Graaff (B)

Menzies Institute for Medical Research, University of Tasmania, Tasmania, Australia.

Julie A Campbell (JA)

Menzies Institute for Medical Research, University of Tasmania, Tasmania, Australia.

Matthew D Jose (MD)

School of Medicine, University of Tasmania, Tasmania, Australia; Australia and New Zealand Dialysis and Transplant Registry (ANZDATA), South Australia, Australia.

John Burgess (J)

School of Medicine, University of Tasmania, Tasmania, Australia; Department of Endocrinology, Royal Hobart Hospital, Tasmania, Australia.

Timothy Saunder (T)

School of Medicine, University of Tasmania, Tasmania, Australia.

Alex Kitsos (A)

School of Medicine, University of Tasmania, Tasmania, Australia.

Caroline Wells (C)

Diabetes Tasmania, Tasmania, Australia.

Andrew J Palmer (AJ)

Menzies Institute for Medical Research, University of Tasmania, Tasmania, Australia. Electronic address: Andrew.Palmer@utas.edu.au.

Classifications MeSH